Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-22 | New | $4,203,742 | $4,203,742 | Equity Only | 06b | SEC link |
| 2023-11-22 | New | $44,394,325 | $44,394,325 | Equity Only | 06b | SEC link |
| 2023-09-08 | New | $10,060,025 | $10,060,025 | Equity Only | 06b | SEC link |
| 2020-01-14 | New | $12,969,616 | $12,969,616 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| James Coffin | Director, Executive |
| Michael Humbert | Executive |
| David Johnson | Director |
| Alexander Koglin | Director, Executive |
| Peter Kolchinsky | Director |
| Edward Liddy | Director |
| Charles Mc Millan | Director |
| Thomas R. Nickoloff | Director |
| Marcel Roche | Executive |
| Nancy Rurkowski | Director |
| David Seldin | Director |
| Andrew Weber | Director |